0001140361-21-016735.txt : 20210510 0001140361-21-016735.hdr.sgml : 20210510 20210510214800 ACCESSION NUMBER: 0001140361-21-016735 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20210506 FILED AS OF DATE: 20210510 DATE AS OF CHANGE: 20210510 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ADVENT INTERNATIONAL CORP/MA CENTRAL INDEX KEY: 0001034196 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36730 FILM NUMBER: 21909422 BUSINESS ADDRESS: STREET 1: 800 BOYLSTON STREET SUITE 3300 CITY: BOSTON STATE: MA ZIP: 02199 BUSINESS PHONE: 6179510555 MAIL ADDRESS: STREET 1: 800 BOYLSTON STREET SUITE 3300 CITY: BOSTON STATE: MA ZIP: 02199 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Advent International GPE VIII Limited Partnership CENTRAL INDEX KEY: 0001664596 STATE OF INCORPORATION: N4 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36730 FILM NUMBER: 21909421 BUSINESS ADDRESS: STREET 1: 800 BOYLSTON STREET SUITE 3300 CITY: BOSTON STATE: MA ZIP: 02119 BUSINESS PHONE: 617-951-9400 MAIL ADDRESS: STREET 1: 800 BOYLSTON STREET SUITE 3300 CITY: BOSTON STATE: MA ZIP: 02119 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Advent International GPE VIII-H Limited Partnership CENTRAL INDEX KEY: 0001664582 STATE OF INCORPORATION: N4 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36730 FILM NUMBER: 21909414 BUSINESS ADDRESS: STREET 1: 800 BOYLSTON STREET, SUITE 3300 CITY: BOSTON STATE: MA ZIP: 02199 BUSINESS PHONE: 617-951-9400 MAIL ADDRESS: STREET 1: 800 BOYLSTON STREET, SUITE 3300 CITY: BOSTON STATE: MA ZIP: 02199 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Advent International GPE VIII-F Limited Partnership CENTRAL INDEX KEY: 0001664584 STATE OF INCORPORATION: N4 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36730 FILM NUMBER: 21909415 BUSINESS ADDRESS: STREET 1: 800 BOYLSTON STREET, SUITE 3300 CITY: BOSTON STATE: MA ZIP: 02199 BUSINESS PHONE: 617-951-9400 MAIL ADDRESS: STREET 1: 800 BOYLSTON STREET, SUITE 3300 CITY: BOSTON STATE: MA ZIP: 02199 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Advent International GPE VIII-B Limited Partnership CENTRAL INDEX KEY: 0001664592 STATE OF INCORPORATION: N4 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36730 FILM NUMBER: 21909420 BUSINESS ADDRESS: STREET 1: 800 BOYLSTON STREET, SUITE 3300 CITY: BOSTON STATE: MA ZIP: 02199 BUSINESS PHONE: 617-951-9400 MAIL ADDRESS: STREET 1: 800 BOYLSTON STREET, SUITE 3300 CITY: BOSTON STATE: MA ZIP: 02199 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Advent International GPE VIII-B-3 Limited Partnership CENTRAL INDEX KEY: 0001665974 STATE OF INCORPORATION: N4 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36730 FILM NUMBER: 21909417 BUSINESS ADDRESS: STREET 1: 800 BOYLSTON STREET, SUITE 3300 CITY: BOSTON STATE: MA ZIP: 02199 BUSINESS PHONE: 617-951-9400 MAIL ADDRESS: STREET 1: 800 BOYLSTON STREET, SUITE 3300 CITY: BOSTON STATE: MA ZIP: 02199 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Advent International GPE VIII-I Limited Partnership CENTRAL INDEX KEY: 0001664748 STATE OF INCORPORATION: N4 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36730 FILM NUMBER: 21909413 BUSINESS ADDRESS: STREET 1: 800 BOYLSTON STREET, SUITE 3300 CITY: BOSTON STATE: MA ZIP: 02199 BUSINESS PHONE: 617-951-9400 MAIL ADDRESS: STREET 1: 800 BOYLSTON STREET, SUITE 3300 CITY: BOSTON STATE: MA ZIP: 02199 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Advent International GPE VIII-D Limited Partnership CENTRAL INDEX KEY: 0001664766 STATE OF INCORPORATION: N4 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36730 FILM NUMBER: 21909416 BUSINESS ADDRESS: STREET 1: 800 BOYLSTON STREET, SUITE 3300 CITY: BOSTON STATE: MA ZIP: 02199 BUSINESS PHONE: 617-951-9400 MAIL ADDRESS: STREET 1: 800 BOYLSTON STREET, SUITE 3300 CITY: BOSTON STATE: MA ZIP: 02199 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Advent International GPE VIII-B-1 Limited Partnership CENTRAL INDEX KEY: 0001665956 STATE OF INCORPORATION: N4 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36730 FILM NUMBER: 21909419 BUSINESS ADDRESS: STREET 1: 800 BOYLSTON STREET SUITE 3300 CITY: BOSTON STATE: MA ZIP: 02199 BUSINESS PHONE: 617-951-9400 MAIL ADDRESS: STREET 1: 800 BOYLSTON STREET SUITE 3300 CITY: BOSTON STATE: MA ZIP: 02199 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Advent International GPE VIII-B-2 Limited Partnership CENTRAL INDEX KEY: 0001665962 STATE OF INCORPORATION: N4 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36730 FILM NUMBER: 21909418 BUSINESS ADDRESS: STREET 1: 800 BOYLSTON STREET, SUITE 3300 CITY: BOSTON STATE: MA ZIP: 02199 BUSINESS PHONE: 617-951-9400 MAIL ADDRESS: STREET 1: 800 BOYLSTON STREET, SUITE 3300 CITY: BOSTON STATE: MA ZIP: 02199 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Syneos Health, Inc. CENTRAL INDEX KEY: 0001610950 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 273403111 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1030 SYNC STREET CITY: MORRISVILLE STATE: NC ZIP: 27560 BUSINESS PHONE: 919-876-9300 MAIL ADDRESS: STREET 1: 1030 SYNC STREET CITY: MORRISVILLE STATE: NC ZIP: 27560 FORMER COMPANY: FORMER CONFORMED NAME: INC Research Holdings, Inc. DATE OF NAME CHANGE: 20140616 4 1 form4.xml FORM 4 X0306 4 2021-05-06 0001610950 Syneos Health, Inc. SYNH 0001034196 ADVENT INTERNATIONAL CORP/MA PRUDENTIAL TOWER, 800 BOYLSTON STREET SUITE 3300 BOSTON MA 02199-8069 true 0001664596 Advent International GPE VIII Limited Partnership C/O ADVENT INTERNATIONAL CORPORATION 800 BOYLSTON STREET, SUITE 3300 BOSTON MA 02199-8069 true 0001664592 Advent International GPE VIII-B Limited Partnership C/O ADVENT INTERNATIONAL CORPORATION 800 BOYLSTON STREET, SUITE 3300 BOSTON MA 02199-8069 true 0001665956 Advent International GPE VIII-B-1 Limited Partnership C/O ADVENT INTERNATIONAL CORPORATION 800 BOYLSTON STREET, SUITE 3300 BOSTON MA 02199-8069 true 0001665962 Advent International GPE VIII-B-2 Limited Partnership C/O ADVENT INTERNATIONAL CORPORATION 800 BOYLSTON STREET, SUITE 3300 BOSTON MA 02199-8069 true 0001665974 Advent International GPE VIII-B-3 Limited Partnership C/O ADVENT INTERNATIONAL CORPORATION 800 BOYLSTON STREET, SUITE 3300 BOSTON MA 02199-8069 true 0001664766 Advent International GPE VIII-D Limited Partnership C/O ADVENT INTERNATIONAL CORPORATION 800 BOYLSTON STREET, SUITE 3300 BOSTON MA 02199-8069 true 0001664584 Advent International GPE VIII-F Limited Partnership C/O ADVENT INTERNATIONAL CORPORATION 800 BOYLSTON STREET, SUITE 3300 BOSTON MA 02199-8069 true 0001664582 Advent International GPE VIII-H Limited Partnership C/O ADVENT INTERNATIONAL CORPORATION 800 BOYLSTON STREET, SUITE 3300 BOSTON MA 02199-8069 true 0001664748 Advent International GPE VIII-I Limited Partnership C/O ADVENT INTERNATIONAL CORPORATION 800 BOYLSTON STREET, SUITE 3300 BOSTON MA 02199-8069 true Class A Common Stock 2021-05-06 4 S 0 3791652 81.04 D 6973097 I See Notes Class A Common Stock 2021-05-06 4 S 0 216666 81.04 D 6756431 I See Notes See Exhibit 99.1 for text of footnote (1). See Exhibit 99.1 for text of footnote (2). See Exhibit 99.1 for text of footnote (3). See Exhibit 99.1 for text of footnote (4). See Exhibit 99.1 for text of footnote (5). Exhibit 99.1 (Footnotes to Form 4) and Exhibit 99.2 (Signatures and Joint Filer Information) are incorporated herein by reference. This Form 4 is the fourth of six Form 4s being filed relating to the same event. This Form 4 has been split into six filings because there are more than 10 Reporting Persons in total, and the SEC's EDGAR filing system limits a single Form 4 to a maximum of 10. Each part will be filed by Designated Filer, Advent International Corporation. See Exhibit 99.2 2021-05-10 EX-99.1 2 brhc10024397_ex99-1.htm EXHIBIT 99.1
Exhibit 99.1
Name and Address of Reporting Person:
 Advent International Corporation
 
 Prudential Tower, 800 Boylston Street, Suite 3300
 
 Boston, MA 02199-8069
   
Issuer Name and Ticker or Trading Symbol:
 Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required to be Reported:
 May 6, 2021
(Month/Day/Year)
  

Footnotes to Form 4
(1) Represents shares of Class A Common Stock (“Common Stock”) of Syneos Health, Inc. (the “Issuer”) sold in connection with a secondary offering of the Issuer’s Common Stock (the “Offering”) by the following entities: 64,792 shares sold by Advent International GPE VIII-C Limited Partnership (“GPE VIII-C”) and 3,726,860 shares sold by Double Eagle Investor Holdings, L.P. (“Double Eagle Investor Holdings”), of which: 773 shares were indirectly sold by Advent Partners GPE VII Limited Partnership, 1,980 shares were indirectly sold by Advent Partners GPE VII 2014 Limited Partnership, 1,828 shares were indirectly sold by Advent Partners GPE VII-A Limited Partnership, 5,426 shares were indirectly sold by Advent Partners GPE VII-A 2014 Limited Partnership, 13,180 shares were indirectly sold by Advent Partners GPE VII (Cayman) Limited Partnership, 4,455 shares were indirectly sold by Advent Partners GPE VII 2014 Cayman Limited Partnership, 3,484 shares were indirectly sold by Advent Partners GPE VII-A (Cayman) Limited Partnership, 18,067 shares were indirectly sold by Advent Partners GPE VII-B (Cayman) Limited Partnership, 3,144 shares were indirectly sold by Advent Partners GPE VII-A 2014 (Cayman) Limited Partnership (collectively, the “Advent Partners GPE VII Funds”); 165,005 shares were indirectly sold by Advent International GPE VII-A Limited Partnership, 366,092 shares were indirectly sold by Advent International GPE VII-E Limited Partnership, 28,615 shares were indirectly sold by Advent International GPE VII-H Limited Partnership (collectively, the “GPE VII GP Funds”); 178,272 shares were indirectly sold by Advent International GPE VII Limited Partnership, 508,241 shares were indirectly sold by Advent International GPE VII-B Limited Partnership, 161,513 shares were indirectly sold by Advent International GPE VII-C Limited Partnership, 106,735 shares were indirectly sold by Advent International GPE VII-D Limited Partnership, 47,130 shares were indirectly sold by Advent International GPE VII-F Limited Partnership, 47,130 shares were indirectly sold by Advent International GPE VII-G Limited Partnership (collectively, the “GPE VII GP S.a.r.l. Funds”); 120,104 shares were indirectly sold by Advent International GPE VIII Limited Partnership, 397,835 shares were indirectly sold by Advent International GPE VIII-B Limited Partnership, 141,171 shares were indirectly sold by Advent International GPE VIII-B-1 Limited Partnership, 105,256 shares were indirectly sold by Advent International GPE VIII-B-2 Limited Partnership, 164,360 shares were indirectly sold by Advent International GPE VIII-B-3 Limited Partnership, 55,411 shares were indirectly sold by Advent International GPE VIII-D Limited Partnership, 16,422 shares were indirectly sold by Advent International GPE VIII-F Limited Partnership, 145,482 shares were indirectly sold by Advent International GPE VIII-H Limited Partnership, 135,283 shares were indirectly sold by Advent International GPE VIII-I Limited Partnership, 132,943 shares were indirectly sold by Advent International GPE VIII-J Limited Partnership (collectively, the “GPE VIII GP S.a.r.l. Funds”); 281,720 shares were indirectly sold by Advent International GPE VIII-A Limited Partnership, 61,713 shares were indirectly sold by Advent International GPE VIII-E Limited Partnership, 104,668 shares were indirectly sold by Advent International GPE VIII-G Limited Partnership, 57,603 shares were indirectly sold by Advent International GPE VIII-K Limited Partnership, 56,689 shares were indirectly sold by Advent International GPE VIII-L Limited Partnership (collectively, the “GPE VIII GP Funds”); 27,679 shares were indirectly sold by Advent Partners GPE VIII Cayman Limited Partnership, 3,685 shares were indirectly sold by Advent Partners GPE VIII-A Cayman Limited Partnership, 47,354 shares were indirectly sold by Advent Partners GPE VIII-B Cayman Limited Partnership, 4,645 shares were indirectly sold by Advent Partners GPE VIII Limited Partnership, and 5,767 shares were indirectly sold by Advent Partners GPE VIII-A Limited Partnership (collectively, the “Advent Partners GPE VIII Funds”).
 
1
(2) Represents shares of Common Stock sold to the Issuer (the “Private Sale”) by the following entities: 3,702 shares sold by GPE VIII-C and 212,964 shares sold by Double Eagle Investor Holdings, of which: 45 were indirectly sold by Advent Partners GPE VII Limited Partnership, 113 shares were indirectly sold by Advent Partners GPE VII 2014 Limited Partnership, 104 shares were indirectly sold by Advent Partners GPE VII-A Limited Partnership, 310 shares were indirectly sold by Advent Partners GPE VII-A 2014 Limited Partnership, 753 shares were indirectly sold by Advent Partners GPE VII (Cayman) Limited Partnership, 255 shares were indirectly sold by Advent Partners GPE VII 2014 Cayman Limited Partnership, 199 shares were indirectly sold by Advent Partners GPE VII-A (Cayman) Limited Partnership, 1,033 shares indirectly sold by Advent Partners GPE VII-B (Cayman) Limited Partnership, 179 shares were indirectly sold by Advent Partners GPE VII-A 2014 (Cayman) Limited Partnership; 9,429 shares were indirectly sold by Advent International GPE VII-A Limited Partnership, 20,919 shares were indirectly sold by Advent International GPE VII-E Limited Partnership, 1,636 shares were indirectly sold by Advent International GPE VII-H Limited Partnership; 10,187 shares were indirectly sold by Advent International GPE VII Limited Partnership, 29,039 shares were indirectly sold by Advent International GPE VII-B Limited Partnership, 9,229 shares were indirectly sold by Advent International GPE VII-C Limited Partnership, 6,099 shares were indirectly sold by Advent International GPE VII-D Limited Partnership, 2,694 shares were indirectly sold by Advent International GPE VII-F Limited Partnership, 2,694 shares were indirectly sold by Advent International GPE VII-G Limited Partnership; 6,863 shares were indirectly sold by Advent International GPE VIII Limited Partnership, 22,734 shares were indirectly sold by Advent International GPE VIII-B Limited Partnership, 8,067 shares were indirectly sold by Advent International GPE VIII-B-1 Limited Partnership, 6,016 shares were indirectly sold by Advent International GPE VIII-B-2 Limited Partnership, 9,392 shares were indirectly sold by Advent International GPE VIII-B-3 Limited Partnership, 3,166 shares were indirectly sold by Advent International GPE VIII-D Limited Partnership, 938 shares were indirectly sold by Advent International GPE VIII-F Limited Partnership, 8,314 shares were indirectly sold by Advent International GPE VIII-H Limited Partnership, 7,730 shares were indirectly sold by Advent International GPE VIII-I Limited Partnership, 7,597 shares were indirectly sold by Advent International GPE VIII-J Limited Partnership; 16,098 shares were indirectly sold by Advent International GPE VIII-A Limited Partnership, 3,526 shares were indirectly sold by Advent International GPE VIII-E Limited Partnership, 5,981 shares were indirectly sold by Advent International GPE VIII-G Limited Partnership, 3,292 shares were indirectly sold by Advent International GPE VIII-K Limited Partnership, 3,239 shares were indirectly sold by Advent International GPE VIII-L Limited Partnership; 1,582 shares were indirectly sold by Advent Partners GPE VIII Cayman Limited Partnership, 211 shares were indirectly sold by Advent Partners GPE VIII-A Cayman Limited Partnership, 2,706 shares were indirectly sold by Advent Partners GPE VIII-B Cayman Limited Partnership, 265 shares were indirectly sold by Advent Partners GPE VIII Limited Partnership, and 330 shares were indirectly sold by Advent Partners GPE VIII-A Limited Partnership.
 
(3) Following the Offering and the Private Sale, Advent manages funds that collectively own 6,756,431 shares, which are represented as follows: 115,455 shares held directly by GPE VIII-C and 6,640,976 shares held directly by Double Eagle Investor Holdings, of which: 1,378 shares are indirectly owned by Advent Partners GPE VII Limited Partnership, 3,527 shares are indirectly owned by Advent Partners GPE VII 2014 Limited Partnership, 3,257 shares are indirectly owned by Advent Partners GPE VII-A Limited Partnership, 9,668 shares are indirectly owned by Advent Partners GPE VII-A 2014 Limited Partnership, 32,485 shares are indirectly owned by Advent Partners GPE VII (Cayman) Limited Partnership, 7,939 shares are indirectly owned by Advent Partners GPE VII 2014 Cayman Limited Partnership, 6,209 shares are indirectly owned by Advent Partners GPE VII-A (Cayman) Limited Partnership, 32,194 shares are indirectly owned by Advent Partners GPE VII-B (Cayman) Limited Partnership, 5,602 shares are indirectly owned by Advent Partners GPE VII-A 2014 (Cayman) Limited Partnership; 294,026 shares are indirectly owned by Advent International GPE VII-A Limited Partnership, 652,347 shares are indirectly owned by Advent International GPE VII-E Limited Partnership, 50,990 shares are indirectly owned by Advent International GPE VII-H Limited Partnership; 317,668 shares are indirectly owned by Advent International GPE VII Limited Partnership, 905,648 shares are indirectly owned by Advent International GPE VII-B Limited Partnership, 287,804 shares are indirectly owned by Advent International GPE VII-C Limited Partnership, 190,193 shares are indirectly owned by Advent International GPE VII-D Limited Partnership, 83,981 shares are indirectly owned by Advent International GPE VII-F Limited Partnership, 83,981 shares are indirectly owned by Advent International GPE VII-G Limited Partnership; 214,017 shares are indirectly owned by Advent International GPE VIII Limited Partnership, 708,911 shares are indirectly owned by Advent International GPE VIII-B Limited Partnership, 251,556 shares are indirectly owned by Advent International GPE VIII-B-1 Limited Partnership, 187,558 shares are indirectly owned by Advent International GPE VIII-B-2 Limited Partnership, 292,878 shares are indirectly owned by Advent International GPE VIII-B-3 Limited Partnership, 98,739 shares are indirectly owned by Advent International GPE VIII-D Limited Partnership, 29,262 shares are indirectly owned by Advent International GPE VIII-F Limited Partnership, 259,237 shares are indirectly owned by Advent International GPE VIII-H Limited Partnership, 241,063 shares are indirectly owned by Advent International GPE VIII-I Limited Partnership, 236,894 shares are indirectly owned by Advent International GPE VIII-J Limited Partnership; 502,003 shares are indirectly owned by Advent International GPE VIII-A Limited Partnership, 109,968 shares are indirectly owned by Advent International GPE VIII-E Limited Partnership, 186,511 shares are indirectly owned by Advent International GPE VIII-G Limited Partnership, 102,644 shares are indirectly owned by Advent International GPE VIII-K Limited Partnership, 101,015 shares are indirectly owned by Advent International GPE VIII-L Limited Partnership; 49,322 shares are indirectly owned by Advent Partners GPE VIII Cayman Limited Partnership, 6,567 shares are indirectly owned by Advent Partners GPE VIII-A Cayman Limited Partnership, 77,278 shares are indirectly owned by Advent Partners GPE VIII-B Cayman Limited Partnership, 8,277 shares are indirectly owned by Advent Partners GPE VIII Limited Partnership, and 10,276 shares are indirectly owned by Advent Partners GPE VIII-A Limited Partnership.

2
(4) Advent is the Sole Member of Double Eagle GP, LLC, which in turn is the General Partner of Double Eagle Investor Holdings. Advent is the Manager of Advent International GPE VII, LLC (“GPE VII LLC”) and Advent International GPE VIII, LLC (“GPE VIII LLC”).

GPE VII, LLC is the General Partner of GPE VII GP S.a.r.l. (“GPE VII GP S.a.r.l.”), GPE VII GP Limited Partnership (“GPE VII GP”), and the Advent Partners GPE VII Funds. GPE VII GP is the General Partner of the GPE VII GP Funds. GPE VII GP S.a.r.l. is the General Partner of the GPE VII GP S.a.r.l. Funds.

GPE VIII LLC is the General Partner of GPE VIII GP Limited Partnership (“GPE VIII GP”), GPE VIII GP S.a.r.l. (“GPE VIII GP S.a.r.l.”), and AP GPE VIII GP Limited Partnership (“AP GPE VIII GP”). GPE VIII GP S.a.r.l. is the General Partner of the GPE VIII GP S.a.r.l. Funds and of GPE VIII-C. GPE VIII GP is the General Partner of the GPE VIII GP Funds. AP GPE VIII GP is the General Partner of the Advent Partners GPE VIII Funds.

(5) Each of the entities named above are referred to herein as “Reporting Persons.” Each Reporting Person disclaims Section 16 beneficial ownership of the shares reported herein except to the extent of its respective pecuniary interest therein, if any, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or any other purpose.


3
 EX-99.2 3 brhc10024397_ex99-2.htm EXHIBIT 99.2
Exhibit 99.2

Joint Filer Information

Name of Joint Filer:
Double Eagle Investor Holdings, L.P.
   
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
   
Relationship of Joint Filer to Issuer:
10% Owner
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
May 6, 2021
   
Designated Filer:
Advent International Corporation

Signature:

DOUBLE EAGLE INVESTOR HOLDINGS, L.P.
By: Double Eagle GP, LLC, its General Partner
By: Advent International Corporation, its Sole Member

By:
/s/ Michael Ristaino
  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

May 10, 2021
Date
Page 1 of 48
Joint Filer Information
 
Name of Joint Filer:
Double Eagle GP, LLC
   
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
   
Relationship of Joint Filer to Issuer:
10% Owner
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
May 6, 2021
   
Designated Filer:
Advent International Corporation

Signature:

DOUBLE EAGLE GP, LLC
By: Advent International Corporation, its Sole Member

By:
/s/ Michael Ristaino
  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

May 10, 2021
Date
Page 2 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VIII-C Limited Partnership
   
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
   
Relationship of Joint Filer to Issuer:
10% Owner
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
May 6, 2021
   
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII-C LIMITED PARTNERSHIP
    
By: GPE VIII GP S.à r.l., its General Partner
    
By: Advent International GPE VIII, LLC, its Manager
/s/ Jarlyth Gibson
  
By: Advent International Corporation, its Manager
Jarlyth Gibson, Manager
  

By:

/s/ Michael Ristaino
  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

May 10, 2021
Date
Page 3 of 48
Joint Filer Information

Name of Joint Filer:
GPE VIII GP S.à r.l.
   
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
   
Relationship of Joint Filer to Issuer:
10% Owner
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
May 6, 2021
   
Designated Filer:
Advent International Corporation

Signature:

GPE VIII GP S.à r.l.
    
By: Advent International GPE VIII, LLC, its Manager
/s/ Jarlyth Gibson
  
By: Advent International Corporation, its Manager
Jarlyth Gibson, Manager
  

By:

/s/ Michael Ristaino
  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

May 10, 2021
Date
Page 4 of 48
Joint Filer Information

Name of Joint Filer:
GPE VIII GP Limited Partnership
   
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
   
Relationship of Joint Filer to Issuer:
10% Owner
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
May 6, 2021
   
Designated Filer:
Advent International Corporation

Signature:

GPE VIII GP LIMITED PARTNERSHIP
By: Advent International GPE VIII, LLC, its General Partner
By: Advent International Corporation, its Manager

By:

/s/ Michael Ristaino
  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

May 10, 2021
Date
Page 5 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VIII, LLC
   
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
   
Relationship of Joint Filer to Issuer:
10% Owner
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
May 6, 2021
   
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII, LLC
By: Advent International Corporation, its Manager

By:

/s/ Michael Ristaino
  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

May 10, 2021
Date
Page 6 of 48
Joint Filer Information

Name of Joint Filer:
GPE VII GP S.à r.l.
   
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
   
Relationship of Joint Filer to Issuer:
10% Owner
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
May 6, 2021
   
Designated Filer:
Advent International Corporation

Signature:

GPE VII GP S.à r.l.
    
By: Advent International GPE VIII, LLC, its Manager
/s/ Jarlyth Gibson
  
By: Advent International Corporation, its Manager
Jarlyth Gibson, Manager
  

By:

/s/ Michael Ristaino
  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

May 10, 2021
Date
Page 7 of 48
Joint Filer Information

Name of Joint Filer:
GPE VII GP Limited Partnership
   
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
   
Relationship of Joint Filer to Issuer:
10% Owner
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
May 6, 2021
   
Designated Filer:
Advent International Corporation

Signature:

GPE VII GP LIMITED PARTNERSHIP
By: Advent International GPE VII, LLC, its General Partner
By: Advent International Corporation, its Manager

By:

/s/ Michael Ristaino
  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

May 10, 2021
Date
Page 8 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VII, LLC
   
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
   
Relationship of Joint Filer to Issuer:
10% Owner
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
May 6, 2021
   
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VII, LLC
By: Advent International Corporation, its Manager

By:

/s/ Michael Ristaino
  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

May 10, 2021
Date
Page 9 of 48
Joint Filer Information

Name of Joint Filer:
AP GPE VIII GP Limited Partnership
   
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
   
Relationship of Joint Filer to Issuer:
10% Owner
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
May 6, 2021
   
Designated Filer:
Advent International Corporation

Signature:

AP GPE VIII GP LIMITED PARTNERSHIP
By: Advent International GPE VIII, LLC, its General Partner
By: Advent International Corporation, its Manager

By:

/s/ Michael Ristaino
  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

May 10, 2021
Date
Page 10 of 48
Joint Filer Information

Name of Joint Filer:
Advent Partners GPE VIII Cayman Limited Partnership
   
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
   
Relationship of Joint Filer to Issuer:
10% Owner
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
May 6, 2021
   
Designated Filer:
Advent International Corporation

Signature:

ADVENT PARTNERS GPE VIII CAYMAN LIMITED PARTNERSHIP
By: AP GPE VIII GP Limited Partnership, its General Partner
By: Advent International GPE VIII, LLC, its General Partner
By: Advent International Corporation, its Manager

By:

/s/ Michael Ristaino
  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

May 10, 2021
Date
Page 11 of 48
Joint Filer Information

Name of Joint Filer:
Advent Partners GPE VIII-B Cayman Limited Partnership
   
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
   
Relationship of Joint Filer to Issuer:
10% Owner
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
May 6, 2021
   
Designated Filer:
Advent International Corporation

Signature:

ADVENT PARTNERS GPE VIII-B CAYMAN LIMITED PARTNERSHIP
By: AP GPE VIII GP Limited Partnership, its General Partner
By: Advent International GPE VIII, LLC, its General Partner
By: Advent International Corporation, its Manager

By:

/s/ Michael Ristaino
  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

May 10, 2021
Date
Page 12 of 48
Joint Filer Information

Name of Joint Filer:
Advent Partners GPE VIII Limited Partnership
   
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
   
Relationship of Joint Filer to Issuer:
10% Owner
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
May 6, 2021
   
Designated Filer:
Advent International Corporation

Signature:

ADVENT PARTNERS GPE VIII LIMITED PARTNERSHIP
By: AP GPE VIII GP Limited Partnership, its General Partner
By: Advent International GPE VIII, LLC, its General Partner
By: Advent International Corporation, its Manager

By:

/s/ Michael Ristaino
  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

May 10, 2021
Date
Page 13 of 48
Joint Filer Information

Name of Joint Filer:
Advent Partners GPE VIII-A Limited Partnership
   
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
   
Relationship of Joint Filer to Issuer:
10% Owner
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
May 6, 2021
   
Designated Filer:
Advent International Corporation

Signature:

ADVENT PARTNERS GPE VIII-A LIMITED PARTNERSHIP
By: AP GPE VIII GP Limited Partnership, its General Partner
By: Advent International GPE VIII, LLC, its General Partner
By: Advent International Corporation, its Manager

By:

/s/ Michael Ristaino
  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

May 10, 2021
Date
Page 14 of 48
Joint Filer Information

Name of Joint Filer:
Advent Partners GPE VIII-A Cayman Limited Partnership
   
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
   
Relationship of Joint Filer to Issuer:
10% Owner
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
May 6, 2021
   
Designated Filer:
Advent International Corporation

Signature:

ADVENT PARTNERS GPE VIII-A CAYMAN LIMITED PARTNERSHIP
By: AP GPE VIII GP Limited Partnership, its General Partner
By: Advent International GPE VIII, LLC, its General Partner
By: Advent International Corporation, its Manager

By:

/s/ Michael Ristaino
  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

May 10, 2021
Date
Page 15 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VII-A Limited Partnership
   
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
   
Relationship of Joint Filer to Issuer:
10% Owner
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
May 6, 2021
   
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VII-A LIMITED PARTNERSHIP
By: GPE VII GP Limited Partnership, its General Partner
By: Advent International GPE VII, LLC, its General Partner
By: Advent International Corporation, its Manager

By:

/s/ Michael Ristaino
  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

May 10, 2021
Date
Page 16 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VII-E Limited Partnership
   
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
   
Relationship of Joint Filer to Issuer:
10% Owner
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
May 6, 2021
   
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VII-E LIMITED PARTNERSHIP
By: GPE VII GP Limited Partnership, its General Partner
By: Advent International GPE VII, LLC, its General Partner
By: Advent International Corporation, its Manager

By:

/s/ Michael Ristaino
  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

May 10, 2021
Date
Page 17 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VII-H Limited Partnership
   
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
   
Relationship of Joint Filer to Issuer:
10% Owner
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
May 6, 2021
   
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VII-H LIMITED PARTNERSHIP
By: GPE VII GP Limited Partnership, its General Partner
By: Advent International GPE VII, LLC, its General Partner
By: Advent International Corporation, its Manager

By:

/s/ Michael Ristaino
  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

May 10, 2021
Date
Page 18 of 48
Joint Filer Information

Name of Joint Filer:
Advent Partners GPE VII Limited Partnership
   
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
   
Relationship of Joint Filer to Issuer:
10% Owner
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
May 6, 2021
   
Designated Filer:
Advent International Corporation

Signature:

ADVENT PARTNERS GPE VII LIMITED PARTNERSHIP
By: Advent International GPE VII, LLC, its General Partner
By: Advent International Corporation, its Manager

By:

/s/ Michael Ristaino
  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

May 10, 2021
Date
Page 19 of 48
Joint Filer Information

Name of Joint Filer:
Advent Partners GPE VII 2014 Limited Partnership
   
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
   
Relationship of Joint Filer to Issuer:
10% Owner
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
May 6, 2021
   
Designated Filer:
Advent International Corporation

Signature:

ADVENT PARTNERS GPE VII 2014 LIMITED PARTNERSHIP
By: Advent International GPE VII, LLC, its General Partner
By: Advent International Corporation, its Manager

By:

/s/ Michael Ristaino
  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

May 10, 2021
Date
Page 20 of 48
Joint Filer Information

Name of Joint Filer:
Advent Partners GPE VII-A Limited Partnership
   
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
   
Relationship of Joint Filer to Issuer:
10% Owner
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
May 6, 2021
   
Designated Filer:
Advent International Corporation

Signature:

ADVENT PARTNERS GPE VII-A LIMITED PARTNERSHIP
By: Advent International GPE VII, LLC, its General Partner
By: Advent International Corporation, its Manager

By:

/s/ Michael Ristaino
  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

May 10, 2021
Date
Page 21 of 48
Joint Filer Information

Name of Joint Filer:
Advent Partners GPE VII-A 2014 Limited Partnership
   
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
   
Relationship of Joint Filer to Issuer:
10% Owner
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
May 6, 2021
   
Designated Filer:
Advent International Corporation

Signature:

ADVENT PARTNERS GPE VII-A 2014 LIMITED PARTNERSHIP
By: Advent International GPE VII, LLC, its General Partner
By: Advent International Corporation, its Manager

By:

/s/ Michael Ristaino
  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

May 10, 2021
Date
Page 22 of 48
Joint Filer Information

Name of Joint Filer:
Advent Partners GPE VII Cayman Limited Partnership
   
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
   
Relationship of Joint Filer to Issuer:
10% Owner
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
May 6, 2021
   
Designated Filer:
Advent International Corporation

Signature:

ADVENT PARTNERS GPE VII CAYMAN LIMITED PARTNERSHIP
By: Advent International GPE VII, LLC, its General Partner
By: Advent International Corporation, its Manager

By:

/s/ Michael Ristaino
  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

May 10, 2021
Date
Page 23 of 48
Joint Filer Information

Name of Joint Filer:
Advent Partners GPE VII 2014 Cayman Limited Partnership
   
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
   
Relationship of Joint Filer to Issuer:
10% Owner
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
May 6, 2021
   
Designated Filer:
Advent International Corporation

Signature:

ADVENT PARTNERS GPE VII 2014 CAYMAN LIMITED PARTNERSHIP
By: Advent International GPE VII, LLC, its General Partner
By: Advent International Corporation, its Manager

By:

/s/ Michael Ristaino
  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

May 10, 2021
Date
Page 24 of 48
Joint Filer Information

Name of Joint Filer:
Advent Partners GPE VII-A Cayman Limited Partnership
   
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
   
Relationship of Joint Filer to Issuer:
10% Owner
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
May 6, 2021
   
Designated Filer:
Advent International Corporation

Signature:

ADVENT PARTNERS GPE VII-A CAYMAN LIMITED PARTNERSHIP
By: Advent International GPE VII, LLC, its General Partner
By: Advent International Corporation, its Manager

By:

/s/ Michael Ristaino
  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

May 10, 2021
Date
Page 25 of 48
Joint Filer Information

Name of Joint Filer:
Advent Partners GPE VII-B Cayman Limited Partnership
   
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
   
Relationship of Joint Filer to Issuer:
10% Owner
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
May 6, 2021
   
Designated Filer:
Advent International Corporation

Signature:

ADVENT PARTNERS GPE VII-B CAYMAN LIMITED PARTNERSHIP
By: Advent International GPE VII, LLC, its General Partner
By: Advent International Corporation, its Manager

By:

/s/ Michael Ristaino
  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

May 10, 2021
Date
Page 26 of 48
Joint Filer Information

Name of Joint Filer:
Advent Partners GPE VII-A 2014 Cayman Limited Partnership
   
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
   
Relationship of Joint Filer to Issuer:
10% Owner
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
May 6, 2021
   
Designated Filer:
Advent International Corporation

Signature:

ADVENT PARTNERS GPE VII-A 2014 CAYMAN LIMITED PARTNERSHIP
By: Advent International GPE VII, LLC, its General Partner
By: Advent International Corporation, its Manager

By:

/s/ Michael Ristaino
  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

May 10, 2021
Date
Page 27 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VIII Limited Partnership
   
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
   
Relationship of Joint Filer to Issuer:
10% Owner
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
May 6, 2021
   
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
By: Advent International GPE VIII, LLC, its Manager
/s/ Jarlyth Gibson
  
By: Advent International Corporation, its Manager
Jarlyth Gibson, Manager
  

By:

/s/ Michael Ristaino
  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

May 10, 2021
Date
Page 28 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VIII-B Limited Partnership
   
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
   
Relationship of Joint Filer to Issuer:
10% Owner
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
May 6, 2021
   
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII-B LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
By: Advent International GPE VIII, LLC, its Manager
/s/ Jarlyth Gibson
  
By: Advent International Corporation, its Manager
Jarlyth Gibson, Manager
  

By:

/s/ Michael Ristaino
  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

May 10, 2021
Date
Page 29 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VIII-B-1 Limited Partnership
   
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
   
Relationship of Joint Filer to Issuer:
10% Owner
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
May 6, 2021
   
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII-B-1 LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
By: Advent International GPE VIII, LLC, its Manager
/s/ Jarlyth Gibson
  
By: Advent International Corporation, its Manager
Jarlyth Gibson, Manager
  

By:

/s/ Michael Ristaino
  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

May 10, 2021
Date
Page 30 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VIII-B-2 Limited Partnership
   
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
   
Relationship of Joint Filer to Issuer:
10% Owner
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
May 6, 2021
   
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII-B-2 LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
By: Advent International GPE VIII, LLC, its Manager
/s/ Jarlyth Gibson
  
By: Advent International Corporation, its Manager
Jarlyth Gibson, Manager
  

By:

/s/ Michael Ristaino
  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

May 10, 2021
Date
Page 31 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VIII-B-3 Limited Partnership
   
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
   
Relationship of Joint Filer to Issuer:
10% Owner
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
May 6, 2021
   
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII-B-3 LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
By: Advent International GPE VIII, LLC, its Manager
/s/ Jarlyth Gibson
  
By: Advent International Corporation, its Manager
Jarlyth Gibson, Manager
  

By:

/s/ Michael Ristaino
  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

May 10, 2021
Date
Page 32 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VIII-D Limited Partnership
   
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
   
Relationship of Joint Filer to Issuer:
10% Owner
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
May 6, 2021
   
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII-D LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
By: Advent International GPE VIII, LLC, its Manager
/s/ Jarlyth Gibson
  
By: Advent International Corporation, its Manager
Jarlyth Gibson, Manager
  

By:

/s/ Michael Ristaino
  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

May 10, 2021
Date
Page 33 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VIII-F Limited Partnership
   
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
   
Relationship of Joint Filer to Issuer:
10% Owner
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
May 6, 2021
   
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII-F LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
By: Advent International GPE VIII, LLC, its Manager
/s/ Jarlyth Gibson
  
By: Advent International Corporation, its Manager
Jarlyth Gibson, Manager
  

By:

/s/ Michael Ristaino
  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

May 10, 2021
Date
Page 34 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VIII-H Limited Partnership
   
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
   
Relationship of Joint Filer to Issuer:
10% Owner
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
May 6, 2021
   
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII-H LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
By: Advent International GPE VIII, LLC, its Manager
/s/ Jarlyth Gibson
  
By: Advent International Corporation, its Manager
Jarlyth Gibson, Manager
  

By:

/s/ Michael Ristaino
  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

May 10, 2021
Date
Page 35 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VIII-I Limited Partnership
   
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
   
Relationship of Joint Filer to Issuer:
10% Owner
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
May 6, 2021
   
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII-I LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
By: Advent International GPE VIII, LLC, its Manager
/s/ Jarlyth Gibson
  
By: Advent International Corporation, its Manager
Jarlyth Gibson, Manager
  

By:

/s/ Michael Ristaino
  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

May 10, 2021
Date
Page 36 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VIII-J Limited Partnership
   
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
   
Relationship of Joint Filer to Issuer:
10% Owner
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
May 6, 2021
   
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII-J LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
By: Advent International GPE VIII, LLC, its Manager
/s/ Jarlyth Gibson
  
By: Advent International Corporation, its Manager
Jarlyth Gibson, Manager
  

By:

/s/ Michael Ristaino
  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

May 10, 2021
Date
Page 37 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VIII-A Limited Partnership
   
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
   
Relationship of Joint Filer to Issuer:
10% Owner
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
May 6, 2021
   
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII-A LIMITED PARTNERSHIP
By: GPE VIII GP Limited Partnership, its General Partner
By: Advent International GPE VIII, LLC, its General Partner
By: Advent International Corporation, its Manager

By:

/s/ Michael Ristaino
  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

May 10, 2021
Date
Page 38 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VIII-E Limited Partnership
   
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
   
Relationship of Joint Filer to Issuer:
10% Owner
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
May 6, 2021
   
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII-E LIMITED PARTNERSHIP
By: GPE VIII GP Limited Partnership, its General Partner
By: Advent International GPE VIII, LLC, its General Partner
By: Advent International Corporation, its Manager

By:

/s/ Michael Ristaino
  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

May 10, 2021
Date
Page 39 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VIII-G Limited Partnership
   
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
   
Relationship of Joint Filer to Issuer:
10% Owner
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
May 6, 2021
   
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII-G LIMITED PARTNERSHIP
By: GPE VIII GP Limited Partnership, its General Partner
By: Advent International GPE VIII, LLC, its General Partner
By: Advent International Corporation, its Manager

By:

/s/ Michael Ristaino
  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

May 10, 2021
Date
Page 40 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VIII-K Limited Partnership
   
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
   
Relationship of Joint Filer to Issuer:
10% Owner
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
May 6, 2021
   
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII-K LIMITED PARTNERSHIP
By: GPE VIII GP Limited Partnership, its General Partner
By: Advent International GPE VIII, LLC, its General Partner
By: Advent International Corporation, its Manager

By:

/s/ Michael Ristaino
  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

May 10, 2021
Date
Page 41 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VIII-L Limited Partnership
   
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
   
Relationship of Joint Filer to Issuer:
10% Owner
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
May 6, 2021
   
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII-L LIMITED PARTNERSHIP
By: GPE VIII GP Limited Partnership, its General Partner
By: Advent International GPE VIII, LLC, its General Partner
By: Advent International Corporation, its Manager

By:

/s/ Michael Ristaino
  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

May 10, 2021
Date
Page 42 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VII Limited Partnership
   
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
   
Relationship of Joint Filer to Issuer:
10% Owner
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
May 6, 2021
   
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VII LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
By: Advent International GPE VII, LLC, its Manager
/s/ Jarlyth Gibson
  
By: Advent International Corporation, its Manager
Jarlyth Gibson, Manager
  

By:

/s/ Michael Ristaino
  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

May 10, 2021
Date
Page 43 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VII-B Limited Partnership
   
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
   
Relationship of Joint Filer to Issuer:
10% Owner
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
May 6, 2021
   
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VII-B LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
By: Advent International GPE VII, LLC, its Manager
/s/ Jarlyth Gibson
  
By: Advent International Corporation, its Manager
Jarlyth Gibson, Manager
  

By:

/s/ Michael Ristaino
  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

May 10, 2021
Date
Page 44 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VII-C Limited Partnership
   
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
   
Relationship of Joint Filer to Issuer:
10% Owner
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
May 6, 2021
   
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VII-C LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
By: Advent International GPE VII, LLC, its Manager
/s/ Jarlyth Gibson
  
By: Advent International Corporation, its Manager
Jarlyth Gibson, Manager
  

By:

/s/ Michael Ristaino
  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

May 10, 2021
Date
Page 45 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VII-D Limited Partnership
   
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
   
Relationship of Joint Filer to Issuer:
10% Owner
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
May 6, 2021
   
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VII-D LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
By: Advent International GPE VII, LLC, its Manager
/s/ Jarlyth Gibson
  
By: Advent International Corporation, its Manager
Jarlyth Gibson, Manager
  

By:

/s/ Michael Ristaino
  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

May 10, 2021
Date
Page 46 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VII-F Limited Partnership
   
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
   
Relationship of Joint Filer to Issuer:
10% Owner
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
May 6, 2021
   
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VII-F LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
By: Advent International GPE VII, LLC, its Manager
/s/ Jarlyth Gibson
  
By: Advent International Corporation, its Manager
Jarlyth Gibson, Manager
  

By:

/s/ Michael Ristaino
  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

May 10, 2021
Date
Page 47 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VII-G Limited Partnership
   
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
   
Relationship of Joint Filer to Issuer:
10% Owner
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
May 6, 2021
   
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VII-G LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
By: Advent International GPE VII, LLC, its Manager
/s/ Jarlyth Gibson
  
By: Advent International Corporation, its Manager
Jarlyth Gibson, Manager
  

By:

/s/ Michael Ristaino
  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

May 10, 2021
Date

Page 48 of 48